BioAge Labs, Inc.
BIOA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Assets | – | – | – |
| Cash & Equivalents | $354 | $22 | $28 |
| Short-Term Investments | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $4 | $0 |
| Total Curr. Assets | $357 | $25 | $28 |
| Property Plant & Equip (Net) | $1 | $1 | $0 |
| Goodwill | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 |
| Total NC Assets | $1 | $1 | $0 |
| Other Assets | $0 | $0 | $0 |
| Total Assets | $358 | $26 | $28 |
| Liabilities | – | – | – |
| Payables | $2 | $2 | $2 |
| Short-Term Debt | $6 | $45 | $0 |
| Tax Payable | $0 | $0 | $0 |
| Deferred Revenue | $8 | $3 | $0 |
| Other Curr. Liab. | $12 | $8 | $3 |
| Total Curr. Liab. | $28 | $58 | $6 |
| LT Debt | $3 | $8 | $2 |
| Deferred Rev, NC | $5 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 |
| Other NC Liab. | $0 | $133 | $133 |
| Total NC Liab. | $7 | $141 | $135 |
| Other Liabilities | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 |
| Total Liabilities | $35 | $199 | $141 |
| Equity | – | – | – |
| Pref Stock | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 |
| Retained Earnings | -$253 | -$182 | -$118 |
| AOCI | $0 | $0 | $0 |
| Other Equity | $576 | $8 | $5 |
| Total Equity | $323 | -$173 | -$113 |
| Supplemental Information | – | – | – |
| Minority Interest | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $358 | $26 | $28 |
| Net Debt | -$346 | $32 | -$25 |